INNT
TOTAL INVALIDATION PROCESSED BY THE IB
19/02/2026
Voltar para busca
Dado oficial do USPTO
TASLY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
20/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
10/11/2016
Data de registro
29/05/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/12/2024
Última transação
20/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CN
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of an outline of a shaded triangle with two cut-outs in the shape of horizontal bars crossing through the top half; a smaller shaded triangle appears inside. To the right of the triangles appears the literal element "TASLY".
Titulares e representantes
Titulares
Tasly Pharmaceutical Group Co., Ltd.
Representantes
Michael D. Schumann Hamre, Schumann, Mueller & Larson, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Raw material medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; pharmaceutical herbs for medical purposes; Prepared Chinese medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Capsules for medicinescapsules sold empty for pharmaceuticals; Pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Dietetic food and beverages adapted for medical use; bath preparationsmedicated; Medical analgesic preparations; preparations for the treatment of burns; Syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; Mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; Pharmaceutical Gelatingelatin capsules sold empty for pharmaceuticals ; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils; medicinal herbs; Lotions for pharmaceutical purposesanti-bacteria hand washing solutionoral washingsgynecological washingsanorectal washings; Ointments for pharmaceutical purposessunburn ointmentsanti-inflammatory ointmentshemorrhoidal ointmentsfrostbite salve for pharmaceutical purposeseye ointments; Pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxesfilled; medicinal roots; medicinal herbal preparationstonics medicine; sedatives; soporifics; sugar for medical purposes; Biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; Diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; Dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; Weight-reducing aidweight management supplements; Medicine for the treatment of sunburns; Food supplementsantioxidants used for medicinal purposes; acne treatment preparation; Medicinal herbal preparationslysine electuary; oral rehydration salts; Medicinal liquor for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Medicinal herbal preparationsginseng electuary; Ginseng for medicinal use; Medicinal herbal preparationsmedlar; Dietetic beverages adapted for medicinal purposesweight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetablesfruits; food for babies; milk powder for infants; air purifying preparations; Medicated animal washes; Veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; Medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/02/2026
INPC
INVALIDATION PROCESSED
01/02/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
13/08/2025
C71T
CANCELLED SECTION 71
13/12/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/09/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2018
FIMP
FINAL DISPOSITION PROCESSED
11/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/08/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
29/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/03/2018
PUBO
PUBLISHED FOR OPPOSITION
13/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/02/2018
RFNT
REFUSAL PROCESSED BY IB
10/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/12/2017
GNRT
NON-FINAL ACTION E-MAILED
21/12/2017
CNRT
NON-FINAL ACTION WRITTEN
21/12/2017
DOCK
ASSIGNED TO EXAMINER
07/12/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/11/2017
RFNT
REFUSAL PROCESSED BY IB
22/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/09/2017
RFRR
REFUSAL PROCESSED BY MPU
01/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/08/2017
CNRT
NON-FINAL ACTION WRITTEN
29/08/2017
MAFR
APPLICATION FILING RECEIPT MAILED
25/08/2017
DOCK
ASSIGNED TO EXAMINER
21/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TASLY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.